Exploring the role of miRSNPs in diagnosis and prognosis of prostate cancer [ 2015 - 2018 ]

Research Grant

Researchers: Dr Jyotsna Batra (Principal investigator)

Brief description Genetic variants, when used alongside PSA and family history, could be a better early biomarker to identify men predisposable to develop prostate cancer or/and to distinguish slowly progressive from aggressive disease. We will undertake a comprehensive study on a special class of genetic variants "miRSNPs" in the non-coding region of the prostate cancer related genes and will also identify their mechanism of action, and their potential as a biomarker for prostate cancer diagnosis and prognosis.

Funding Amount $AUD 428,065.07

Funding Scheme Career Development Fellowships

Notes RD Wright Biomedical CDF